EUVIMEDEUVIMED entdecken
Crossref

Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence

Jinna Ren, Tianjiao Chu, Bozhao Li, Suying Wu, Zhenlin Yang, Gengtian Sun, Zefang Lu, Feilong Qi, Feifan Wu, Yue Peng, Mengyao Li, Yuliang Zhao und 3 weitere

Advanced Materials · 2025

DOI: 10.1002/adma.202417708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Jinna Ren und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Dentistry II, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Resear…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Immunotherapy, Angiogenesis Inhibitors, Cancer Vaccines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Key R&D Program of China, National Key Research and Development Program of China, Strategic Priority Research Program of the Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immune‐suppressive microenvironment and extensive tumor angiogenesis are key contributors to the high recurrence and mortality rates of oral squamous cell carcinoma (OSCC). To address these challenges, a personalized 3D‐printed anti‐tumor vaccine (3D‐Vax‐L) is developed that integrates whole tumor antigens from postoperative tissue lysates with the angiogenesis inhibitor, lenvatinib. This vaccine not only possesses inherent adjuvant properties but also mimics the functions of lymph nodes through its porous structure, facilitating the recruitment and maturation of immune cells. In vivo studies in OSCC animal models, including mice and rabbits, demonstrate that 3D‐Vax‐L effectively recruits and matures immune cells at postoperative sites, inhibits angiogenesis and tumor recurrence, and extends survival time, all while maintaining a stable morphology and an excellent biosafety. Furthermore, 3D‐Vax‐L supports facial integrity post‐surgery, addressing physical challenges by preventing collapse and reducing the risk of aesthetic‐related disorders. These findings suggest that 3D‐Vax‐L is a promising therapeutic technique for preventing post‐surgical OSCC relapse, particularly as it offers a new strategy for immune system activation and demonstrates significant potential for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsImmunotherapyAngiogenesis InhibitorsCancer VaccinesNeoplasm Recurrence, LocalCarcinoma, Squamous CellAnimalsMiceHumansRabbitsPrinting, Three-DimensionalCell Line, TumorPhenylurea CompoundsNeovascularization, PathologicPrecision MedicineQuinolines

Stichwörter der Autor:innen

3D printing scaffoldanti‐angiogenesiscancer immunotherapycancer personalized vaccinecombination therapy

Substanzen

Angiogenesis InhibitorsCancer VaccineslenvatinibPhenylurea CompoundsQuinolines

Autor:innen und Institutionen

  • Department of General Dentistry II, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of…
  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
  • School of Astronautics, Harbin Institute of Technology, Harbin, 150001, China.
  • Institutes of Biomedical Sciences, Inner Mongolia University, Hohhot, 010070, China.
  • Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Department of Thoracic Surgery, National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.

ORCID-Profile: Guangjun Nie, Yuguang Wang, Suping Li

Förderung

  • National Key R&D Program of China
  • National Key Research and Development Program of China
  • Strategic Priority Research Program of the Chinese Academy of Sciences
  • Young Scientists in Basic Research
  • National Natural Science Foundation of China

Zitieren

APA

Ren, J., Chu, T., Li, B., Wu, S., Yang, Z., Sun, G., Lu, Z., Qi, F., Wu, F., Peng, Y., Li, M., Zhao, Y., Nie, G., Wang, Y., & Li, S. (2025). Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence. Advanced Materials. https://doi.org/10.1002/adma.202417708

Vancouver

Ren J, Chu T, Li B, Wu S, Yang Z, Sun G, et al. Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence. Advanced Materials. 2025. doi:10.1002/adma.202417708

BibTeX
@article{Ren2025,
  author = {Ren, Jinna and Chu, Tianjiao and Li, Bozhao and Wu, Suying and Yang, Zhenlin and Sun, Gengtian and Lu, Zefang and Qi, Feilong and Wu, Feifan and Peng, Yue and Li, Mengyao and Zhao, Yuliang and Nie, Guangjun and Wang, Yuguang and Li, Suping},
  title = {Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202417708}
}
Kostenlos starten →